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Abstract
 
Helicobacter pylori
 
 infection induces various gastroduodenal diseases. We examined the role of
two genes, 
 
vacA
 
 and 
 
cagE
 
, in the gastric pathogenesis induced by 
 
H. pylori
 
 using a long-term
(62 wk) animal model. Reportedly, both genes are associated with the virulence of 
 
H. pylori
 
:
 
vacA 
 
encodes vacuolating cytotoxin, and 
 
cagE
 
, with other genes in the 
 
cag
 
 pathogenicity islands,
encodes a type IV secretion system. Mongolian gerbils were challenged in this study by a wild-
type TN2 strain and its isogenic mutants of 
 
cagE
 
 or 
 
vacA
 
. The wild-type and 
 
vacA
 
 mutants in-
duced severe gastritis, whereas 
 
cagE
 
 mutants induced far milder changes. Gastric ulcer was in-
duced at the highest rate (22/23) by the wild-type TN2, followed by the 
 
vacA
 
 mutant (19/28).
No ulcer was found in the gerbils infected with the 
 
cagE
 
 mutant (0/27) or in controls (0/27).
Intestinal metaplasia was also found in the gerbils infected with the wild-type (14/23) or 
 
vacA
 
mutant (15/28). Gastric cancer developed in one gerbil with wild-type infection and in one
with 
 
vacA
 
 mutant infection. In conclusion, the knocking out of the 
 
cagE
 
 gene deprived wild-
type 
 
H. pylori
 
 of the pathogenicity for gastritis and gastric ulcer, suggesting that the secretion
system encoded by 
 
cag 
 
pathogenicity island genes plays an essential role.
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Introduction
 
Helicobacter pylori
 
 is a gram-negative bacterium infecting hu-
man gastric mucosa with worldwide prevalence. This bac-
terium plays an important role in the pathogenesis of
chronic gastritis, peptic ulcers, gastric adenocarcinomas,
and gastric mucosa–associated lymphoid tissue lymphomas
(1–4).
Several factors have been proposed as possible virulence
determinants. Among them, the CagA protein, encoded by
 
the 
 
cagA
 
 gene, is found in 
 
z
 
50–60% of isolates in Western
countries and is reportedly associated with advanced gas-
troduodenal diseases (5–8). CagA-positive strains report-
edly induce IL-8 secretion in gastric epithelial cells (9).
Moreover, recent studies showed that the 
 
cagA
 
 gene is a
 
member of the 
 
cag
 
 pathogenicity island (PAI),
 
1
 
 a 40-kb re-
gion of supposedly extraneous origin (10). Isogenic mutant
studies demonstrated that some 
 
cag 
 
PAI genes, including
 
cagE
 
, which was initially reported as 
 
picB
 
, are essential for
 
IL-8 induction and nuclear factor (NF)-
 
k
 
B activation (10–
14). Recent studies indicated that 
 
cagE
 
 and several other
genes of 
 
cag
 
 PAI code a type IV secretion system, which
translocates CagA protein inside the gastric epithelial cells
to be tyrosine phosphorylated by a yet unknown mecha-
nism (15–17). Indeed, deletion of 
 
cagE
 
 was found to impair
the translocation of CagA.
 
VacA
 
 is a polymorphic gene encoding vacuolating cyto-
toxin, and the strains producing active cytotoxin are usually
 
cagA
 
 positive and toxigenic (18–21). The VacA protein
causes vacuolation in cultured cells and is considered a cy-
totoxin (19). The strains that possess vacuolating activity are
isolated from chronic gastritis and peptic ulcer patients at
high frequency (22, 23). A recent study showed that VacA
alters the intracellular trafficking of proteins, increases the
permeability of polarized epithelial cells, inhibits the process
of antigen presentation, forms anion-selective channels in
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lipid bilayers, and interferes with cytoskeleton-dependent
cell functions (24). However, in spite of various studies on
VacA in vitro and in vivo, the exact role of VacA in gastric
pathogenesis in vivo remains to be understood.
Animals used for studying experimental 
 
H. pylori
 
 infec-
tion include monkeys, dogs, piglets, domestic cats, and ro-
dents (25–31). Several of the described models are not opti-
mal because the animals can not be handled with ease or in
large numbers, germ-free conditions are necessary, and in-
fection rates are low. Infection of conventional mice with
 
H. pylori
 
 overcomes many of problems, although infection
is not easily achieved, and the gastritis in mice induced by
 
H. pylori
 
 is less intense than in humans (32). The Mongo-
lian gerbil is an animal in which various gastrointestinal dis-
eases such as gastritis, ulcers, intestinal metaplasia, and gas-
tric cancer can be appropriately developed (33–35). We
previously reported that TN2GF4, which shares an ances-
tral strain with TN2, the wild-type (WT) strain used in this
study, induced gastric cancer in gerbils without using adju-
vant chemical carcinogens (34). It was also reported that
isogenic mutants of 
 
vacA
 
 and 
 
cagA
 
 colonized well, allowing
for examination of the role of virulence markers on gastric
pathogenesis in Mongolian gerbils (36, 37). We conducted
this study to examine the pathological consequences of
long-term infection with WT and mutant (
 
D
 
cagE
 
, 
 
D
 
vacA
 
)
 
H. pylori
 
 strains using specific pathogen–free Mongolian
gerbils to evaluate the role played by those genes in gastric
pathogenesis.
 
Materials and Methods
 
Bacterial Strains and Culture Conditions.
 
An
 
 H. pylori 
 
clinical
isolate (TN2) and its two isogenic mutants (TN2
 
D
 
cagE
 
 and
TN2
 
D
 
vacA
 
) were used in this study. TN2, a strain positive for the
vacuolating cytotoxin and 
 
cag 
 
PAI, shares an ancestral strain with
TN2GF4, which we previously reported to induce gastric cancer
in Mongolian gerbils (34). 
 
H. pylori
 
 cells were cultured in Bru-
cella broth culture medium (Becton Dickinson) containing 2.5%
FBS (Cansera International, Inc.) and Glaxo selective supplement
A (10 mg/liter vancomycin, 3.3 mg/liter polymyxin B, 20 mg/li-
ter bacitracin, 10.7 mg/liter nalidixic acid, and 5 mg/liter am-
photericin B) in a microaerophilic atmosphere generated by
CampyPak-Plus (Becton Dickinson) at 37
 
8
 
C for 24 h. Cultures
were supplemented with sterilized glycerol at a final concentra-
tion of 15% and were stored at 
 
2
 
80
 
8
 
C until use.
 
Construction of Isogenic cagE-negative Mutant (TN2
 
D
 
cagE) and
vacA-negative Mutant (TN2
 
D
 
vacA).
 
The 
 
cagE
 
 mutant strain of
TN2 was constructed as described previously (13). In brief, 
 
cagE
 
gene was amplified using the long PCR method with primers
HPPB-1F and HPPB-1R and then cloned into the plasmid vec-
tor pCRII (Invitrogen), named pCR/CE. The cloned
 
 cagE
 
 gene
was disrupted by insertion of a kanamycin resistance gene (km
 
r
 
)
cassette at nucleotide position 212, which resulted in pCR/CE::
km. DNA from plasmid pCR/CE::km was transferred into the
TN2 strain by electroporation. The bacteria were recovered and
plated onto nonselective plates and incubated for 24 h. Then, the
bacteria were transferred onto agar plates with kanamycin. Kana-
mycin-resistant 
 
H. pylori
 
 colonies were screened for the allelic ex-
change by PCR, and the disruption in 
 
cagE
 
 gene was confirmed
by Southern hybridization.
The 
 
vacA
 
 mutant of TN2 was also constructed as described
(14), and disruption of the 
 
vacA
 
 gene was confirmed by means of
Southern hybridization and PCR using primers vacA-C1 and
vacA-C2 (21). A loss of vacuolation activity was checked by use
of a vacuolating assay.
 
Animals.
 
5-wk-old male specific pathogen–free Mongolian
gerbils (MON/Jms/Gbs Slc) were purchased from Japan SLC,
Inc. and maintained under standard laboratory conditions (room
temperature, 23 
 
6
 
 2
 
8
 
C; relative humidity 55 
 
6
 
 5%; 12/12-h
light/dark cycle) with free access to a commercial rodent diet
(CE-2; Clea Japan) and tap water. All experimental protocols de-
scribed were conducted in accordance with the Guidelines for
the Care and Use of Laboratory Animals in the Pharmaceutical
Research Division of Takeda Chemical Industries, Ltd. and ap-
proved by the Ethical Committee specializing in animal experi-
ments for our division.
 
Adaptation for Infection.
 
Six animals were inoculated with
broth culture containing 5.4 
 
6 
 
0.7 
 
3 
 
10
 
7
 
 CFUs of TN2 (WT),
TN2
 
D
 
cagE
 
, or TN2
 
D
 
vacA 
 
via intragastric gavage after fasting for
24 h. Animals were killed 2–3 wk after inoculation, and stomachs
were used for quantitative culture. New gerbils were inoculated
with recovered bacteria, and infecting bacteria were recovered 3
wk after inoculation. These steps were repeated three times, and
the efficiency of infection was assessed at each stage.
 
Long-Term Infection Model.
 
125 animals were divided into
four groups. WT groups consisted of 31 animals that were inocu-
lated with 1 ml of 
 
H. pylori
 
 TN2 broth culture via intragastric
gavage after fasting for 24 h. Both the 
 
D
 
cagE
 
 and 
 
D
 
vacA
 
 groups,
each consisting of 31 animals, were challenged with TN2
 
D
 
cagE
 
or TN2
 
D
 
vacA
 
, respectively. Each inoculated broth culture con-
tained 5.5 
 
6 
 
0.5 
 
3 
 
10
 
7
 
 CFUs of bacteria. 32 animals served as in-
tact controls without the challenge of bacterium. The body
weight of animals was checked every 3 mo. Animals were killed
62 wk after inoculation, and stomachs were divided into halves.
One half was fixed in Carnoy’s fixative for histological examina-
tion, and the other half was used for quantitative determination
of the bacterium by culture.
 
Culture Study.
 
The number of the infecting bacteria in the
stomach was measured as previously described (34). In brief, after
the stomach was opened along the greater curvature, the longitu-
dinal half was homogenized with physiological saline. Modified
Skirrow’s agar was inoculated with a diluted aliquot and incu-
bated for 4 d at 37
 
8
 
C under microaerobic conditions. Colonies
were identified as 
 
H. pylori
 
 by morphology and urease activity.
The number of colonies per plate was counted and calculated as
the log CFU per gastric wall. Genotyping by PCR and testing for
kanamycin resistance of the recovered bacteria from three animals
of each group were performed to confirm the stability of the mu-
tation during infection.
 
Histological Examination.
 
The half of the stomach to be used
for histopathological examination was stapled onto paper and
fixed in Carnoy’s fixative. Fixed gastric tissue was cut into longi-
tudinal strips for histopathological examination. After processing
for histology by routine methods, paraffin-embedded sections
were cut and stained with hematoxylin and eosin (H&E) or with
alcian blue, pH 2.5, periodic acid-Schiff (AB-PAS). Histopatho-
logical lesions of the glandular stomach were categorized as fol-
lows: (1) mild gastritis (gastritis with mild mononuclear cell infil-
tration and lymphoid follicle formation in the pyloric region); (2)
severe gastritis (gastritis with dense neutrophil and mononuclear
cell infiltrations, multiple lymphoid follicle formations, and hy-
perplastic epithelium throughout the pyloric region and a part of
the fundic region); (3) ulcer; (4) intestinal metaplasia (diagnosed 
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by the presence of goblet cells positive for AB-PAS staining); (5)
adenocarcinoma (diagnosed by the presence of atypical glands lo-
cally invading the muscle layer and destroying the original archi-
tecture); and (6) carcinoid (diagnosed by neuroendocrine nests
greater than three glands in diameter).
 
DNA Preparation and PCR. Chromosomal DNA was isolated
using SepaGene (Sanko Junyaku) from cultures of TN2,
TN2DcagE, and TN2DvacA before and after three passages
through gerbils and cultures isolated from each three animals after
long-term infection with TN2, TN2DcagE, or TN2DvacA. PCR
was carried out in 50-ml volumes containing 100 ng of genomic
DNA, 0.5 U of AmpliTaq DNA polymerase (Applied Biosys-
tems) or LA Taq (Takara Shuzo), 25 pmol of each primer, and 10
nmol of each deoxynucleoside triphosphate in a standard buffer.
Cycling conditions were 30 cycles at 948C for 15 s, 508C for 15 s,
and 728C for a time dependent on the expected product size (1
min per kilobase). The PCR primers used in this study are shown
in Table I (38).
Reverse Transcription–PCR. RNA was prepared from 24-h
broth cultures of WT or mutant H. pylori strains using ISOGEN
(NipponGene). A 10-mg sample of each RNA was treated with
RNase-free DNase I (Roche Diagnostics) to remove contaminat-
ing DNA. We next prepared cDNA from a 2-mg aliquot of the
DNase-treated RNA samples by use of Super Script II RNase H2
Reverse Transcriptase (GIBCO BRL) and random hexamer oli-
gonucleotide primers. The reaction mixtures were diluted to 20
ml with H2O, and 1 ml of each was used as a template for PCR
with oligonucleotide primers specific for cagA, cagF, cagH, or
HP0888 (Table I). DNase-treated RNA samples were also diluted
at the same concentration and used as a template for PCR to con-
firm that DNA was removed from the RNA samples.
Statistical Methods. The body weights of gerbils were com-
pared by one-factor ANOVA (analysis of variance). The inci-
dence of gastric lesion formation was compared by Fisher’s exact
probability test followed by the Holm’s correction for multiple
comparison. The differences were considered significant when
the P value was ,0.05.
Results
Colonization Efficiency of WT and Isogenic Mutant H. pylori
Strains. To assess colonization ability in the gerbil’s stom-
ach, gerbils were inoculated with WT or mutants of H. py-
lori and killed 2–3 wk after inoculation, and the stomachs
were then cultured for H. pylori (Table II). Recovered bac-
teria were cultured in vitro and then inoculated in other
animals up to the third stage of in vivo passage. The strain
TN2DcagE did not achieve an efficient rate of infection
during the first stage, whereas WT and TN2DvacA infected
the gerbils without failure. However, the rate of successful
infection improved after in vivo passage. Those strains re-
covered after three passages were used for the 62-wk long-
term infection study.
Long-Term Infection of WT and Mutant Strains. 31 ani-
mals in each group were inoculated with TN2, TN2DvacA,
or TN2DcagE, and 32 animals served as the intact control
group. During the 62 wk after inoculation, eight, four,
three, and five animals died in the WT, DcagE, DvacA, and
control groups, respectively. The mean body weight of
surviving animals at 62 wk was 66 g in the WT, 77 g in the
DcagE, 76 g in the DvacA, and 90 g in the control group
(Fig. 1). Concerning mortality, there were no significant
differences between groups other than the body weight
curves, which were significantly lower in the WT than in
the mutant and control group. Culture and histological ex-
amination were performed in 23, 27, 28, and 27 animals of
each group (WT, DcagE, DvacA, and control, respectively;
Table III). H. pylori was recovered from all animals in the
challenged groups except for one animal in the WT group,
and H. pylori was not cultured from animals in the control
group. Bacteria density (log CFU per gastric wall) was
(mean  6 SE) 5.48 6 0.28, 5.53 6 0.15, 5.53 6 0.20, and
zero in the WT, DcagE, DvacA, and control groups, respec-
tively (Table III).
Histological Examination. The histopathologic changes
in the gastric mucosa of gerbils infected with H. pylori for
Table I. Primers Used in This Study
Region Primer Nucleotide sequence
cagA cagA-F 59-AACAGGACAAGTAGCTAGCC*
cagA-R 59-GATAACAGGCAAGCTTTTGA*
cagE HPPB-1F 59-TCTATAAAGAGAGGGGTGTT‡
HPPB-1R 59-GGCTAATCTTTGGTAATCAG‡
cagF cagF-F 59- ATGAAACAAATTTGCGTGA§
cagF-R 59-TCAATCGTTATTTTTGTTTT§
cagH cagH-F 59-ATGGCAGGTACACAAGCTAT§
cagH-R 59-TCACTTCACGATTATTTTAG§
cagM cagM-F 59-ATGCTTGCAAAAATTGTTTT*
cagM-R 59-CTATTCAAAGGGATTATTCT*
cagT cagT-F 59-CCATGTTTATACGCCTGTGT*
cagT-R 59-CATCACCACACCCTTTTGAT*
left end of cag cagLEC-F 59-ACATTTTGGCTAAATAAACGCTG*
cagLEC-R1 59-TCTCCATGTTGCCATTATGCTi
vacA vacA-C1 59-ATGGAAATACAACAAACACACCGCA¶
vacA-C2 59-TTAGAAACTATACCTCATTCCTAAA¶
HP0887-0888 HP887F 59-TCATAGCGATTGGCGTGGAA**
HP888R 59-GCTTGGAATTAGAGTCCTTA**
HP0888 HP888F 59-ATGAACGCTGGAGTTTTACA**
HP888R 59-GCTTGGAATTAGAGTCCTTA**
*Reference 38.
‡Reference 13.
§Available from EMBL/GenBank/DDBJ under accession no. U60176.
iAvailable from EMBL/GenBank/DDBJ under accession no. AC000108.
¶Reference 21.
**Available from EMBL/GenBank/DDBJ under accession no. AE000511.
Table II. Adaptation for Infection after Mutagenesis
1st stage 2nd stage 3rd stage
TN2 (WT) 6/6 (100) 5/5 (100) 5/5 (100)
TN2DcagE 2/6 (33) 5/5 (100) 5/5 (100)
TN2DvacA 6/6 (100) 5/5 (100) 5/5 (100)
Number of infected animals/total number of challenged animals
(percentage with infection) are shown.1604 The Factors of Helicobacter pylori Responsible for Gastric Diseases
62 wk are shown in Figs. 2–4 and summarized in Table IV.
Inflammation was significantly reduced in the gerbils in-
fected with TN2DcagE compared with those infected with
TN2 or TN2DvacA. However, no significant differences
were found in histopathological changes induced by TN2
or TN2DvacA. Severe gastritis was observed in all animals
(100%) infected with TN2 and in 26 out of 28 animals
(93%) infected with TN2DvacA. In these animals, dense in-
filtration of neutrophils and mononuclear cells and multiple
lymphoid follicle formation were observed in the lamina
propria and submucosa throughout the pyloric region as
well as the adjacent part of the fundic region (Fig. 2, A, C,
E, and G). The normal mucosal architecture was almost
completely lost in these areas and replaced with hyperplas-
tic epithelium. The mucosal layer was thickened remark-
ably, and pseudopyloric gland formation, cystic glandular
dilatation, and invagination into the submucosa of hyper-
plastic glands were frequently noted. Animals infected with
TN2DcagE, however, showed much milder gastritis (Fig. 2,
B and F) restricted to the pyloric region and characterized
by mild mononuclear cell infiltration with lymphoid folli-
cle formation. Neutrophil activity and epithelial changes
were rarely seen. No evidence of gastritis was found in any
of the control animals (Fig. 2, D and H).
Gastric ulcers were found in 22 out of 23 animals (96%)
with TN2 and in 19 out of 28 animals (68%) with
TN2DvacA. Ulcers were localized in the region of the fun-
dus–pylorus border, and all ulcer lesions reached the sub-
mucosa or the proper muscular layer (Fig. 3, A and C). No
gastric ulcers were found in animals with TN2DcagE or an-
imals of the control group (Fig. 3, B and D). The preva-
lence of gastric ulcers was significantly higher in animals
challenged with TN2 or TN2DvacA than in animals with
TN2DcagE or in controls (P , 0.0001 for all pairs). In the
DvacA group, the number of animals suffering from gastric
ulcers was reduced significantly compared with the WT
group (P 5 0.013). Intestinal metaplasia, formed mainly
near the ulcer (Fig. 4 B), was found in 14 out of 23 (61%),
zero out of 27 (0%), 15 out of 28 (54%), and zero out of 27
(0%) animals in the WT, DcagE, DvacA, and control group,
respectively.
An adenocarcinoma developed in two animals, one in
the WT group and another in the DvacA group. Both tu-
mors were located in the pyloric region, grew downward,
and penetrated into the muscle layer (Fig. 4 A). The tu-
mors retained a well-preserved glandular structure and con-
Figure 1. Changes in body weight of Mongolian gerbils inoculated
orally with H. pylori TN2 (s) and its isogenic vacA (m) or cagE (h) mu-
tants and intact control gerbils (r). The data and error bars represent
means and the standard error of body weights.
Table III. Bacterial Counts within the Gastric Wall of Mongolian 
Gerbils 62 wk after Oral Challenge of H. pylori
Strain Infection rate Bacterial recovery
n Positive (%) Log CFU per stomach*
TN2 (WT) 23 22 (96) 5.48 6 0.28
TN2DcagE 27 27 (100) 5.53 6 0.15
TN2DvacA 28 28 (100) 5.53 6 0.20
Intact control 27 0 (0) Not detected
*Mean 6 SE.
Figure 2. Histopathological findings in the gastric mucosa of gerbils 62
wk after H. pylori inoculation. Gastritis (A–D, pyloric region; and E–H,
fundic region): severe gastritis characterized by dense neutrophil and
mononuclear cell infiltrations and epithelial hyperplasia can be seen in the
animals infected with TN2 (A and E) and TN2DvacA (C and G). The
gastritis extends throughout the pyloric region (A and C) and into a part
of the fundic region (E and G). Mucosal thickness increases remarkably as
compared with uninfected animals (D and H). Only mononuclear cell in-
filtration and lymphoid follicle formation are noted in the pyloric region
of animals infected with TN2DcagE, and neutrophil infiltration and epi-
thelial alterations are not evident (B). There was no inflammation in the
fundic regions of animals infected with TN2DcagE (F). H&E stain; origi-
nal magnifications 353.1605 Ogura et al.
sisted of well-differentiated columnar intestinal-type epi-
thelium. In addition, carcinoids derived from the fundic
mucosa were detected in one animal (4%) in the WT
group and five animals (18%) in the DvacA group. These
carcinoids were arranged in solid sheets or small nests in the
deep lamina propria and occasionally spread into the sub-
mucosa (Fig. 4 C). Neither adenocarcinomas nor carcinoids
were found in the gerbils in the DcagE group and control
group. The incidence of gastric cancer and carcinoid did
not differ significantly among the groups.
Genomic Stability of H. pylori through Infection Study.
The stability of the H. pylori genome through in vivo pas-
sages was examined for the intended mutation and for
the cag PAI. The disruption of the cagE and vacA genes in
recovered bacteria from three animals of each infected
group was confirmed as stable based on the size of the am-
plicons by PCR as compared with the original mutants. All
recovered mutants were resistant to kanamycin, indicating
that the kanamycin cassette still worked after 62 wk of in-
fection (data not shown). The presence of five regions
(cagA, cagF, cagM, cagT, and cagLEC) in cag PAI was exam-
ined by PCR. All cultures examined revealed positive am-
plification for the five regions (data not shown).
Detection of Gene Expression by Reverse Transcription–
PCR. To investigate whether insertion of an antibiotic
resistance cassette into cagE or vacA had polar effects on ex-
pression of the flanking genes located downstream of inser-
tion, we performed reverse transcription (RT)-PCR on
RNA samples prepared from WT strain (TN2), cagE mu-
tant, and vacA mutant. Control PCR experiments verified
that DNA was efficiently removed from RNA samples by
DNase treatment. We then applied cDNA prepared from
these samples to PCR experiments with oligonucleotide
primers specific for the cagA, cagF, cagH, and HP0888 genes
(Table I). A primer pair for the cagA gene, used as positive
control of RT-PCR, produced amplicons of expected size
in these strains to similar extent, indicating that cDNA was
properly prepared from each sample. The RT-PCR prod-
uct of the cagF or cagH gene was also amplified in
TN2DcagE as well as in TN2, indicating that the kmr cas-
sette insertion into cagE had no polar effect on transcription
of cagF or cagH. This finding agrees with the previous re-
port with Northern blot showing that cagE ( picB) was
cotranscribed with only picA, which is located upstream of
cagE (12). Transcription of the HP0888 gene, which is lo-
cated downstream of vacA (HP0887) in strain 26695, was
also analyzed by RT-PCR (39). The primer pair encom-
passing the vacA gene and HP0888 amplified the expected
product in the TN2 genome, indicating that the HP0888
gene is located downstream of vacA in TN2 genome as in
that of the 26695 genome. RT-PCR analysis showed no
difference in the transcription of HP0888 between TN2
and TN2DvacA, suggesting that the insertion of the kmr
cassette into vacA gene did not affect the transcription of
Figure 3.  Ulcers, extending to the muscular layer, developed in the
region of the fundus–pylorus border of animals infected with TN2 (A) or
TN2DvacA (C). No gastric ulcers are seen in animals infected with
TN2DcagE (B) or uninfected animals (D). H&E stain; original magnifica-
tions 103.
Figure 4. Other histopathological findings. Adenocarcinoma (A): an
adenocarcinoma observed in animals infected with TN2. Neoplastic
glands consisted of well-differentiated intestinal-type epithelium (inset)
and penetrated into the muscle layer. Intestinal metaplasia (B): intestinal
metaplasia observed in animals infected with TN2. Metaplastic epithe-
lium containing AB-PAS–positive goblet cells frequently formed near the
ulcer. Carcinoids (C): carcinoids detected in the animal infected with
TN2DvacA. A and C, H&E stain; original magnifications 15 (A) and 803
(C). A, inset, and B, AB-PAS: original magnifications 80 (A, inset) and
303 (B).1606 The Factors of Helicobacter pylori Responsible for Gastric Diseases
HP0888. This result is consistent with the previous report
that vacA gene is most likely transcribed alone (40).
Discussion
In this study, the role of virulence factors in the patho-
genesis of H. pylori infection was investigated using Mon-
golian gerbils as an in vivo animal model. For this purpose,
targeted genes were disrupted by homologous recombina-
tion, and the pathogenicity was compared in WT strains
and isogenic mutants. All gerbils except one were infected
with WT and mutant strains throughout this long-term
study. Disruption of the genes did not affect the ability of
H. pylori to colonize and replicate in the gerbil’s stomach.
Animals in every group survived for 62 wk, with only a
few deaths, and the survival rate of each group did not dif-
fer significantly. However, gains in body weight differed
significantly.
In humans, the effect of H. pylori infection on nutritional
status of the host remains controversial. Reportedly, sus-
tained H. pylori infection is associated with growth failure in
Gambian infants (41). Fall et al. (42) also reported that in
England, low weight at 1 y of age was associated with in-
creased H. pylori seropositivity rates in males, although they
did not decide whether H. pylori infection was the cause of
growth failure or whether small infants were more suscepti-
ble to infection. On the other hand, there were reports
from Bangladesh, Guatemala, and Nicaragua that found no
association between H. pylori infection and malnutrition in
children or infants (43–45). Quinonez et al. (44) concluded
that the small differences in the nutritional status between
the infected and uninfected children may be due to socio-
demographic factors. The results of this study show that ex-
perimental infection with H. pylori, especially the WT, has
led to a significant reduction in body weight 3 mo after in-
oculations. This infection model is purely experimental and,
in design, is not affected by factors other than infection.
Therefore, our observations indicate that infection with H.
pylori may interfere with normal growth in Mongolian ger-
bils and further suggests that the same can occur in humans.
The colonization ability of H. pylori strains, especially
TN2DcagE, was improved after the three passages through
gerbils. It is known that the cag PAI often is lost during hu-
man infection, and it is discussed that strains that lost cag
PAI may grow better than the cag PAI–positive parental
strains in a subset of humans (46). To characterize the iso-
lates obtained after the three passages through gerbils and
the isolates after long-term infection in comparison with
the pre-challenge strains, we examined the existence of
genes in cag PAI by PCR. No major deletion of cag PAI
was found, and it is possible that cag PAI does not affect ad-
aptational capacity for infection in gerbils.
Deletions of the cag PAI and several cag insertion muta-
tions reportedly block the induction of proinflammatory
cytokine IL-8 in gastric epithelial cells in vitro (10, 13, 47).
Recently, reports have noted the presence of cag PAI in as-
sociation with H. pylori–mediated NF-kB activation in gas-
tric epithelial cells, which is a critical regulator of the genes
involved in inflammation, proliferation, and apoptosis (14,
48). The proteins encoded by genes located in cag PAI are
suggested to function as secretion machinery exporting
molecules possibly involved in H. pylori–host cell interac-
tion (10, 49). In addition, CagA protein is noted to be
translocated into gastric cells via cag PAI system and to be
phosphorylated (15–17). The cagE gene is a homologue of
the transporter component in Agrobacterium tumefaciens and
Bordetella pertussis that engages in the transcellular transport
of molecules (12). In this study, the role of the cagE gene
product was assessed using gene disruption in an animal
model suitable for the assessment of the pathogenesis of H.
pylori infection. CagE knockout mutants, which possibly
have a defect in the secretion apparatus, could not cause se-
vere gastritis or induce the metaplastic changes often fol-
lowed by the development of cancer (50). The WT and
vacA-disrupted strains, however, induced severe gastritis
and metaplasia in the gastric mucosa of gerbils, indicating
the role of CagE protein in the pathogenesis of inflamed
gastric mucosa. Moreover, it is tempting to speculate that
the product of the cagE gene, one of the functional genes in
cag PAI, may play a crucial role in the carcinogenesis that
Table IV. Histological Findings in the Stomachs of Gerbils 62 wk after Oral Challenge of H. pylori
Strain: TN2 (WT) TN2DcagE TN2DvacA Intact control
No. of animals: 23 27 28 27
Gastritis 23 (100) 27 (100) 28 (100) 0 (0)*
(Severe) 23 (100) 0 (0)* 26 (93) 0 (0)*
Gastric ulcer 22 (96) 0 (0)* 19 (68)** 0 (0)*
Intestinal metaplasia 14 (61) 0 (0)* 15 (54) 0 (0)*
Adenocarcinoma 1 (4) 0 (0) 1 (4) 0 (0)
Carcinoid 1 (4)  0 (0) 5 (18) 0 (0)
Rates are shown as percentages in parentheses. Significant differences against WT infection by means of Fisher’s exact probability are indicated as the
following: *P , 0.0001 and **P 5 0.013.1607 Ogura et al.
accompanies H. pylori infection. Reportedly, other genes in
cag PAI are also required in host–bacterial interactions in
vitro; however, their in vivo role was not assessed in this
study. Further investigations are necessary to elucidate the
roles of other cag PAI genes in vivo.
The VacA protein has been regarded as a potential can-
didate responsible for the virulence of H. pylori as well as
the cause of inflammation and ulcer formation in the stom-
ach and duodenum (22–24, 51). However, as the VacA-
positive strains often have intact cag PAI (52, 53), the
responsibility of VacA in inducing gastritis and ulcer for-
mation is still controversial. Oral administration of the pu-
rified cytotoxin caused ulceration in mice (51), and recent
investigations revealed the pathogenic effect of VacA in ep-
ithelial cells. VacA inhibited the conversion of procathepsin
D and the intracellular degeneration of epidermal growth
factor (54) and also interfered with cytoskeleton-dependent
cell functions and the transmission of signals related to cell
spreading and growth (24). On the other hand, Ghiara et
al. (55) suggest that VacA does not play an important role
in eliciting inflammation using a mouse model with sonic
extracts of H. pylori. Weel et al. (7) also reported that their
analysis of clinical isolates showed an association of peptic
ulcer disease with only CagA, not VacA.
In our study, Mongolian gerbils were challenged with
the vacA knockout strain to assess the role played by vacu-
olating activity in pathogenesis in vivo. The vacA-disrupted
strain caused inflammatory changes in the stomachs of ger-
bils to a degree similar to that in the WT, indicating that
VacA or the vacuolating activity of bacteria is not essential
for the inflammatory response of gastric mucosa. Gastric ul-
cer was induced in 96% of the animals infected with the
WT strain, 68% of those infected with TN2DvacA, and in
none of those infected with TN2DcagE. This result also in-
dicates the important role, direct or indirect, of the cagE
gene product in the pathogenesis of gastric ulcers. On the
other hand, the disruption of vacA gene reduced the inci-
dence of gastric ulcers significantly, although gastric ulcers
were observed nevertheless in more than half of the animals
in the DvacA group. These results suggest that vacA is not
involved in the inflammation of gastric mucosa but may be
partially responsible for gastric ulcer formation. However,
there is a possibility that VacA is not directly involved in
ulcerogenesis but still worsens gastric ulcer or delays its
healing by degenerating epidermal growth factor (54) or
interfering with cytoskeleton-dependent cell function (24).
In our previous study, 37% of gerbils contracted gastric
cancer 62 wk after inoculation with the same WT H. pylori
strain, TN2. In this study, two gerbils (one from the WT
group and another from the DvacA group) developed gas-
tric cancer, and none from the DcagE or control group did.
Thus, the incidence of cancer development (4%) in this
study was smaller than that reported in our previous study
(34). Possibly, employment of a different breeder (Japan
SLC, Inc.) of Mongolian gerbils (MON/Jms/Gbs Slc) in
this study caused the difference in the incidence of cancer.
Intestinal metaplasia also developed in fewer animals with
WT TN2 (61%) than in our previous study (85%) when
using the same time interval of 62 wk after inoculation.
Therefore, a possible reason for the low incidence of cancer
in this study may be the slow progression of chronic
changes in the gastric mucosa as metaplasia due to genetic
diversity of the host or unexpected differences in environ-
mental factors. In fact, another long-term (z64 wk) exper-
iment using 28 gerbils with TN2 infection confirmed the
incidence of gastric adenocarcinoma as 21% (data not
shown), with gerbils (MGS/Sea) purchased from the same
breeder (Seiwa Experimental Animals) that was used in the
previous study. Both breeders provided us with the descen-
dants of 20 pairs of Mongolian gerbils captured at the Amur
Basin in 1935. However, the ancestries of MGS/Sea di-
verged in 1973 and were separately inbred since that time,
and those of MON/Jms/Gbs Slc diverged in 1979 and
were inbred. Therefore, it is possible that there is a genetic
diversity between the MGS/Sea and MON/Jms/Gbs Slc
gerbils that may affect the inflammatory response as well as
the process of carcinogenesis. Thus, it will be extremely in-
teresting to further study the relation of gastric pathogenesis
with genetic diversity of the host (Mongolian gerbil) and
that of the infecting agent (H. pylori) and may eventually
reveal the underlying mechanism of gastric carcinogenesis.
In conclusion, we showed in this study that cagE is re-
sponsible for various gastric lesions induced in the gerbils
model, and in the future, this experimental animal model
may help to elucidate the virulence factors responsible for
gastric carcinogenesis. It has also been suggested that cag
PAI may play an important role in the pathogenesis of gas-
tric diseases related to H. pylori infection also in humans.
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